Healworth Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-04-2024
- Paid Up Capital ₹ 0.99 M
as on 24-04-2024
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2015
- Satisfied Charges ₹ 5.00 M
as on 24-04-2024
- Revenue %
(FY 2015)
- Profit 86.09%
(FY 2015)
- Ebitda -146.80%
(FY 2015)
- Net Worth -21.16%
(FY 2015)
- Total Assets -86.88%
(FY 2015)
About Healworth Life Sciences
- CIN/LLPIN
U73100CT2008PTC020739
- Company No.
020739
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2008
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Healworth Life Sciences?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitant Shah  | Director | 08-Jul-2008 | Current |
| Komal Chopda | Director | 08-Jul-2008 | Current |
| Rishabh Chopda | Director | 08-Jul-2008 | Current |
| Ashish Chopda | Director | 08-Jul-2008 | Current |
| Shashank Shah | Director | 08-Jul-2008 | Current |
| Hiralal Shah | Director | 08-Jul-2008 | Current |
Financial Performance of Healworth Life Sciences.
Healworth Life Sciences Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 86.09% increase in profit. The company's net worth observed a substantial decline by a decrease of 21.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healworth Life Sciences?
Unlock access to Healworth Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rishabh Laboratories Pvt LtdActive 30 years 11 monthsKomal Chopda, Rishabh Chopda and 1 more are mutual person
- Regalis Life Sciences Private LimitedActive 8 years 5 months
Komal Chopda, Rishabh Chopda and 1 more are mutual person
- Aspire Pharmaceuticals Private LimitedActive 4 years 1 month
Rishabh Chopda and Ashish Chopda are mutual person
- Bahubali Motors Private LimitedActive 19 years 2 months
Shashank Shah and Hiralal Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 02 Aug 2013 | ₹5.00 M | Satisfied |
How Many Employees Work at Healworth Life Sciences?
Unlock and access historical data on people associated with Healworth Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healworth Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healworth Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
